ATE335091T1 - Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen - Google Patents

Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen

Info

Publication number
ATE335091T1
ATE335091T1 AT94921209T AT94921209T ATE335091T1 AT E335091 T1 ATE335091 T1 AT E335091T1 AT 94921209 T AT94921209 T AT 94921209T AT 94921209 T AT94921209 T AT 94921209T AT E335091 T1 ATE335091 T1 AT E335091T1
Authority
AT
Austria
Prior art keywords
rna
samples derived
corresponding applications
sequence
probes
Prior art date
Application number
AT94921209T
Other languages
English (en)
Inventor
Henri Tiedge
Juergen Brosius
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Application granted granted Critical
Publication of ATE335091T1 publication Critical patent/ATE335091T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT94921209T 1993-05-28 1994-05-25 Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen ATE335091T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6865993A 1993-05-28 1993-05-28

Publications (1)

Publication Number Publication Date
ATE335091T1 true ATE335091T1 (de) 2006-08-15

Family

ID=22083939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94921209T ATE335091T1 (de) 1993-05-28 1994-05-25 Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen

Country Status (7)

Country Link
US (2) US5670318A (de)
EP (1) EP0701629B1 (de)
JP (1) JPH08510649A (de)
AT (1) ATE335091T1 (de)
CA (1) CA2163249A1 (de)
DE (1) DE69434809T2 (de)
WO (1) WO1994028176A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60327468D1 (de) 2002-02-22 2009-06-10 Univ New York State Res Found Molekulare diagnose und prognose von karzinomen
AU2003290718A1 (en) * 2002-11-12 2004-07-22 The Research Foundation Of The State University Of New York TRANSLATIONAL CONTROL BY SMALL, NON-TRANSLATABLE RNAs
US7862307B2 (en) * 2003-04-17 2011-01-04 Zexel Valeo Climate Control Corporation Swash plate compressor
KR101447227B1 (ko) 2011-07-28 2014-10-07 한국과학기술원 BC200 RNA에 대한 siRNA를 포함하는 종양전이 억제용 약학조성물
US9777334B2 (en) 2012-04-30 2017-10-03 The Research Foundation for State University of New York Cancer blood test using BC200 RNA isolated from peripheral blood for diagnosis and treatment of invasive breast cancer
KR101482165B1 (ko) 2012-12-27 2015-01-15 한국과학기술원 Rna에 특이적으로 결합하는 항체 및 이의 선별방법
KR101644043B1 (ko) * 2014-03-18 2016-08-01 한국과학기술원 Rna에 특이적으로 결합하는 항체
WO2016054591A1 (en) 2014-10-03 2016-04-07 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
US20260053852A1 (en) * 2022-06-15 2026-02-26 Cedars-Sinai Medical Center Noncoding rna agents (bcyrn1 and derivatives thereof) to treat diseases of immunity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI63596C (fi) * 1981-10-16 1983-07-11 Orion Yhtymae Oy Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
CA1260372A (en) * 1984-04-27 1989-09-26 Elazar Rabbani Hybridization method for the detection of genetic materials
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4751177A (en) * 1985-06-13 1988-06-14 Amgen Methods and kits for performing nucleic acid hybridization assays
US4868105A (en) * 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
EP0238332A2 (de) * 1986-03-19 1987-09-23 Cetus Corporation Flüssiges Hybridisationsverfahren und Satz zum Nachweis der Anwesenheit von Nukleinsäuresequenzen in Proben

Also Published As

Publication number Publication date
WO1994028176A3 (en) 1995-02-16
US5670318A (en) 1997-09-23
CA2163249A1 (en) 1994-12-08
EP0701629A1 (de) 1996-03-20
EP0701629B1 (de) 2006-08-02
JPH08510649A (ja) 1996-11-12
DE69434809D1 (de) 2006-09-14
WO1994028176A2 (en) 1994-12-08
DE69434809T2 (de) 2007-03-29
US5736329A (en) 1998-04-07

Similar Documents

Publication Publication Date Title
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
ES2118593T3 (es) Analogos de nucleotidos de pteridina como sondas fluorescentes de adn.
BG101355A (en) Viral material and nucleotide fragments related to multiplesclerosis, for the diagnostics, prophylaxy and treatment of thisdisease
DE69620906D1 (de) Antisense-oligonukleotidmodulation der raf-genexpression
ATE266737T1 (de) Künstliche fehlhybridisierung
EP0881914A4 (de)
PT1053313E (pt) Oligonucleotidos ''antisense'' optimizados complementares de sequencias de dna metiltransferase
EP1123414A4 (de) Antisense modulation der expression von integrin alpha 4
ATE335091T1 (de) Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen
ATE317436T1 (de) Genveränderung im gen für die g$g(b)3- untereinheit des humanen g-proteins
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
DE69816467D1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
WO1999028439A3 (fr) Erythrovirus et ses applications
ATE166395T1 (de) Für c.difficile spezifische oligonukleotide
DE59812837D1 (de) Orotidin-5'-phosphatdecarboxylase-gen, genkonstrukt enthaltend dieses gen und seine verwendung
AU4136797A (en) Novel semaphorin gene: semaphorin y
DE69836484D1 (de) Endogene retrovirale sequenzen, verwandten mit auto-immune krankheiten oder mit schwangerschaftsstörungen
EP1064402A4 (de) Antisense modulierung von lfa-3
EP1908835A3 (de) Regulierung von Genexpression durch einkettige, monomere, ligandenabhängige Polypeptidschalter
MXPA01004291A (es) Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
FI973762A0 (fi) Ny gen
WO2002072883A3 (de) Nukleotidträger zur diagnose und therapie oraler erkrankungen
AU2001287860A1 (en) Transglutaminase gene products
WO2000029622A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
DK1056872T3 (da) DNA-sekvenser indeholdende en overförselsmekanisme ved konjugering

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties